Bide Pharmatech Hits Day Low at CNY 47.98 Amid Price Pressure

Bide Pharmatech Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock dropping by 8.97% on March 23, 2026. The stock reached an intraday low of CNY 47.98, reflecting a challenging trading environment. In comparison to the broader market, Bide Pharmatech's performance has been notably weaker. Over the past week, the stock has decreased by 16.95%, while the China Shanghai Composite index fell by 6.65%. The one-month performance shows a decline of 18.79%, against a 6.58% drop in the index. Year-to-date, Bide Pharmatech has seen a 20.56% decrease, contrasting sharply with the index's decline of 3.92%. Despite these recent setbacks, the company has reported positive financial metrics, including a notable increase in net sales and a decrease in raw material costs. With a return on equity of 6.97% and a price-to-book ratio of 3.56, Bide Pharmatech maintains an attractive valuation profile within its industry.